StockData
BioVie Inc. logo

BioVie Inc. (BIVI) stock

BIVINasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as BIVIW
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/30
$1.00−0.08 (-7.84%)

Close on Nov 17, 2026Market cap $7.51MP/E –Yield –

BioVie ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

Quarterly ebitda

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q3 FY2022CQ1 2022Mar 31, 2022-$5.69M–
Q3 FY2021CQ1 2021Mar 31, 2021-$2.94M–

More BioVie figures

See a number that looks wrong?